Adage Capital Partners’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.77M | Buy |
+1,280,000
| New | +$4.77M | 0.01% | 708 |
|
|
2024
Q3 | – | Sell |
-975,000
| Closed | -$6.64M | – | 936 |
|
|
2024
Q2 | $6.64M | Buy |
975,000
+125,000
| +15% | +$851K | 0.01% | 673 |
|
|
2024
Q1 | $5.58M | Sell |
850,000
-200,000
| -19% | -$1.31M | 0.01% | 683 |
|
|
2023
Q4 | $6.81M | Buy |
1,050,000
+950,000
| +950% | +$6.17M | 0.01% | 653 |
|
|
2023
Q3 | $503K | Sell |
100,000
-50,000
| -33% | -$252K | ﹤0.01% | 781 |
|
|
2023
Q2 | $1.31M | Buy |
+150,000
| New | +$1.31M | ﹤0.01% | 757 |
|